\-\ Texto\\:\\ \ \(0\)\
\-\ examination\\:\\ \ \(12\)\
\-\ scalp\\:\\ diffuse\\ nonscarring\\ alopecia\\,\\ erythema\\ and\\ fine\\ scales\ \(0\)\
\-\ face\\:\\ heliotrope\\ eruption\\ on\\ eyelids\ \(0\)\
\-\ arms\\:\\ large\\ violacious\\ lichenified\\ plaques\\ in\\ a\\ photo\\-\ \(0\)\
\-\ distrubution\ \(1\)\
\-\ back\\:\\ diffuse\\ erythematous\\ patch\\ in\\ a\\ shawl\\-like\\ distribution\ \(0\)\
\-\ hands\\:\\	erythematous\\ extensor\\ tendon\\ plaques\\;\\ gottron\\'s\ \(0\)\
\-\ papules\\ over\\ mcp\\ and\\ pip\\ joints\\ \ \(0\)\
\-\ fingernails\\:\\ proximal\\ nail\\ folds\\ with\\ dilated\\ and\\ tortuous\\ capillaries\\ with\\ dropout\\ and\\ ragged\\ cuticles\ \(0\)\
\-\ legs\\:\\ violaceous\\ plaques\\ on\\ knees\\ and\\ extensor\\ thighs\ \(0\)\
\-\ therapeutic\\ trials\\ in\\ the\\ past\\ with\\ prednisone\\,\\ cyclosporine\\,\\ accutane\\,\\ plaquenil\\,\\ and\\ methotrexate\\ were\\ discontinued\\ secondary\\ to\\ adverse\\ effects\\ \\(i\\.e\\ recurrent\\ transaminitis\\)\\.\\ from\\ january\\ 1996\\ to\\ december\\ 2001\\ monthly\\ ivig\\ stabilized\\ her\\ disease\\ activity\\.\\ she\\ started\\ etanercept\\ injections\\ in\\ december\\ 2001\\ and\\ has\\ had\\ significantly\\ decreased\\ exacerbations\\ of\\ her\\ muscle\\ disease\\.\\ she\\ is\\ followed\\ closely\\ by\\ gyn\\ and\\ had\\ a\\ normal\\ gynecologic\\ exam\\,\\ mammogram\\,\\ chest\\ x\\-ray\\,\\ and\\ screening\\ colonoscopy\\ in\\ 2002\\.\ \(0\)\
\-\ labs\\:\\ ana\\ positive\\ 1\\:320\\ speckled\\;\\ anti\\-rnp\\,\\ anti\\-smith\\,\\ anti\\-ro\\/la\\,\\ anti\\-jo\\ antibodies\\ negative\\;\\ mri\\ of\\ lower\\ extremities\\ demonstrated\\ extensive\\ atrophy\\ with\\ minimal\\ inflammation\\;\\ emg\\ consistant\\ with\\ myopathic\\ disease\\;\\ history\\ of\\ slightly\\ elevated\\ ck\\ and\\ aldolase\\ when\\ symptomatic\\;\\ hepatitis\\ panel\\ negative\\.\ \(0\)\
\-\ histopathology\\:\\ the\\ biopsy\\ shows\\ epidermal\\ atrophy\\ with\\ compact\\ orthokeratotic\\ hyperkeratosis\\,\\ focal\\ vacuolar\\ interface\\ dermatitis\\,\\ dilated\\ vessels\\,\\ and\\ an\\ increase\\ in\\ dermal\\ interstitial\\ mucin\\.\ \(0\)\
\-\ case\\ 5\\,\\ \\(27th\\ annual\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ 2003\\)\\ dermatomyositis\ \(0\)\
\-\ \\â\\€\\¢\\ sle\ \(0\)\
\-\ \\â\\€\\¢rosacea\ \(1\)\
\-\ \\â\\€\\¢drug\\ eruption\ \(1\)\
\-\ history\\:\\ a\\ 55\\ year\\ old\\ caucasian\\ female\\ with\\ a\\ nine\\ year\\ history\\ of\\ dermatomyositis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ plaques\\:\\ 0\\.18915254232720136\ \(0\)\
\-\ eruption\\:\\ 0\\.162529485413532\ \(0\)\
\-\ dermatomyositis\\:\\ 0\\.15431964326654643\ \(0\)\
\-\ december\\:\\ 0\\.15173891992651142\ \(0\)\
\-\ and\\:\\ 0\\.1420490370838983\ \(0\)\
\-\ extensor\\:\\ 0\\.13424295849757786\ \(0\)\
\-\ erythematous\\:\\ 0\\.12687057460983855\ \(0\)\
\-\ atrophy\\:\\ 0\\.11824890828372916\ \(0\)\
\-\ 2001\\:\\ 0\\.11798650007199699\ \(0\)\
\-\ nonscarring\\:\\ 0\\.09994096023674534\ \(0\)\
\-\ violacious\\:\\ 0\\.09994096023674534\ \(0\)\
\-\ lichenified\\:\\ 0\\.09994096023674534\ \(0\)\
\-\ distrubution\\:\\ 0\\.09994096023674534\ \(0\)\
\-\ myopathic\\:\\ 0\\.09994096023674534\ \(0\)\
\-\ orthokeratotic\\:\\ 0\\.09994096023674534\ \(0\)\
\-\ heliotrope\\:\\ 0\\.09549892296782457\ \(0\)\
\-\ cuticles\\:\\ 0\\.09549892296782457\ \(0\)\
\-\ accutane\\:\\ 0\\.09549892296782457\ \(0\)\
\-\ plaquenil\\:\\ 0\\.09549892296782457\ \(0\)\
\-\ ivig\\:\\ 0\\.09549892296782457\ \(0\)\
\-\ aldolase\\:\\ 0\\.09549892296782457\ \(0\)\
\-\ in\\:\\ 0\\.09327836004443386\ \(0\)\
\-\ scales\\:\\ 0\\.0923472473689213\ \(0\)\
\-\ fingernails\\:\\ 0\\.0923472473689213\ \(0\)\
\-\ dropout\\:\\ 0\\.0923472473689213\ \(0\)\
\-\ transaminitis\\:\\ 0\\.0923472473689213\ \(0\)\
\-\ etanercept\\:\\ 0\\.08990261785226107\ \(0\)\
\-\ compact\\:\\ 0\\.08990261785226107\ \(0\)\
\-\ vacuolar\\:\\ 0\\.08990261785226107\ \(0\)\
\-\ dilated\\:\\ 0\\.08951813954987982\ \(0\)\
\-\ ragged\\:\\ 0\\.08790521010000053\ \(0\)\
\-\ speckled\\:\\ 0\\.08790521010000053\ \(0\)\
\-\ hyperkeratosis\\:\\ 0\\.08790521010000053\ \(0\)\
\-\ alopecia\\:\\ 0\\.0862164259083914\ \(0\)\
\-\ nail\\:\\ 0\\.0862164259083914\ \(0\)\
\-\ with\\:\\ 0\\.08565927338915895\ \(0\)\
\-\ cyclosporine\\:\\ 0\\.08475353450109727\ \(0\)\
\-\ gynecologic\\:\\ 0\\.08346317283107975\ \(0\)\
\-\ eyelids\\:\\ 0\\.08230890498443702\ \(0\)\
\-\ capillaries\\:\\ 0\\.081264742706766\ \(0\)\
\-\ violaceous\\:\\ 0\\.081264742706766\ \(0\)\
\-\ exacerbations\\:\\ 0\\.081264742706766\ \(0\)\
\-\ consistant\\:\\ 0\\.081264742706766\ \(0\)\
\-\ monthly\\:\\ 0\\.08031149723217648\ \(0\)\
\-\ ck\\:\\ 0\\.07943459640031421\ \(0\)\
\-\ disease\\:\\ 0\\.07869784956873381\ \(0\)\
\-\ thighs\\:\\ 0\\.07862271304056737\ \(0\)\
\-\ diffuse\\:\\ 0\\.07838251458830602\ \(0\)\
\-\ her\\:\\ 0\\.07808498185626345\ \(0\)\
\-\ trials\\:\\ 0\\.07786686771551625\ \(0\)\
\-\ adverse\\:\\ 0\\.07786686771551625\ \(0\)\
\-\ negative\\:\\ 0\\.07737878991629948\ \(0\)\
\-\ discontinued\\:\\ 0\\.07715982163327322\ \(0\)\
\-\ antibodies\\:\\ 0\\.07715982163327322\ \(0\)\
\-\ mucin\\:\\ 0\\.07715982163327322\ \(0\)\
\-\ stabilized\\:\\ 0\\.07586945996325571\ \(0\)\
\-\ dermatitis\\:\\ 0\\.07527713128414905\ \(0\)\
\-\ patch\\:\\ 0\\.07471519211661298\ \(0\)\
\-\ she\\:\\ 0\\.07440196858855025\ \(0\)\
\-\ january\\:\\ 0\\.07418067577164658\ \(0\)\
\-\ epidermal\\:\\ 0\\.07418067577164658\ \(0\)\
\-\ gyn\\:\\ 0\\.07367102983894194\ \(0\)\
\-\ 27th\\:\\ 0\\.07367102983894194\ \(0\)\
\-\ pip\\:\\ 0\\.07318404247045995\ \(0\)\
\-\ dermal\\:\\ 0\\.07318404247045995\ \(0\)\
\-\ nine\\:\\ 0\\.07318404247045995\ \(0\)\
\-\ ana\\:\\ 0\\.07271778436435244\ \(0\)\
\-\ history\\:\\ 0\\.07162858274404035\ \(0\)\
\-\ papules\\:\\ 0\\.07142742269433494\ \(0\)\
\-\ mcp\\:\\ 0\\.07142742269433494\ \(0\)\
\-\ methotrexate\\:\\ 0\\.0702731548476922\ \(0\)\
\-\ tortuous\\:\\ 0\\.06922899257002117\ \(0\)\
\-\ injections\\:\\ 0\\.06890194106239003\ \(0\)\
\-\ interface\\:\\ 0\\.06827574709543167\ \(0\)\
\-\ 1996\\:\\ 0\\.067683418416325\ \(0\)\
\-\ folds\\:\\ 0\\.06739884626356939\ \(0\)\
\-\ closely\\:\\ 0\\.06712147924878893\ \(0\)\
\-\ sle\\:\\ 0\\.066329176612568\ \(0\)\
\-\ emg\\:\\ 0\\.0660773169711179\ \(0\)\
\-\ prednisone\\:\\ 0\\.06583111757877143\ \(0\)\
\-\ panel\\:\\ 0\\.06559032960263592\ \(0\)\
\-\ knees\\:\\ 0\\.0651240714965284\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.0651240714965284\ \(0\)\
\-\ effects\\:\\ 0\\.06489817871221341\ \(0\)\
\-\ hepatitis\\:\\ 0\\.06424717066466612\ \(0\)\
\-\ fine\\:\\ 0\\.06363268745445766\ \(0\)\
\-\ scalp\\:\\ 0\\.06343528730491928\ \(0\)\
\-\ therapeutic\\:\\ 0\\.06324138114740423\ \(0\)\
\-\ arms\\:\\ 0\\.06305084744240046\ \(0\)\
\-\ histopathology\\:\\ 0\\.06305084744240046\ \(0\)\
\-\ seminar\\:\\ 0\\.06286357088381471\ \(0\)\
\-\ uniformed\\:\\ 0\\.06232021596483414\ \(0\)\
\-\ had\\:\\ 0\\.06227327389769723\ \(0\)\
\-\ legs\\:\\ 0\\.061470533561621875\ \(0\)\
\-\ services\\:\\ 0\\.06130822819456598\ \(0\)\
\-\ dermatology\\:\\ 0\\.06114829233371514\ \(0\)\
\-\ mammogram\\:\\ 0\\.059665572121195457\ \(0\)\
\-\ hands\\:\\ 0\\.05925724863924051\ \(0\)\
\-\ significantly\\:\\ 0\\.058735463744743956\ \(0\)\
\-\ annual\\:\\ 0\\.0577610073982889\ \(0\)\
\-\ interstitial\\:\\ 0\\.056653457796842076\ \(0\)\
\-\ erythema\\:\\ 0\\.056548620519338254\ \(0\)\
\-\ face\\:\\ 0\\.056341908501924026\ \(0\)\
\-\ 2003\\:\\ 0\\.05623999695868685\ \(0\)\
\-\ caucasian\\:\\ 0\\.05555198721815163\ \(0\)\
\-\ tendon\\:\\ 0\\.05455121276707773\ \(0\)\
\-\ joints\\:\\ 0\\.053714515326741936\ \(0\)\
\-\ 55\\:\\ 0\\.053714515326741936\ \(0\)\
\-\ distribution\\:\\ 0\\.053012505057916166\ \(0\)\
\-\ started\\:\\ 0\\.05264109959538387\ \(0\)\
\-\ screening\\:\\ 0\\.05076609995341747\ \(0\)\
\-\ inflammation\\:\\ 0\\.050225723532410664\ \(0\)\
\-\ increase\\:\\ 0\\.05016729453046486\ \(0\)\
\-\ recurrent\\:\\ 0\\.05010917549815695\ \(0\)\
\-\ of\\:\\ 0\\.048918927175046194\ \(0\)\
\-\ slightly\\:\\ 0\\.048748195634099996\ \(0\)\
\-\ vessels\\:\\ 0\\.04849517256548411\ \(0\)\
\-\ extensive\\:\\ 0\\.04815047948899031\ \(0\)\
\-\ symptomatic\\:\\ 0\\.048053955411756145\ \(0\)\
\-\ minimal\\:\\ 0\\.04767614514816663\ \(0\)\
\-\ extremities\\:\\ 0\\.04749201624422008\ \(0\)\
\-\ activity\\:\\ 0\\.045881765807523754\ \(0\)\
\-\ muscle\\:\\ 0\\.0443746299124211\ \(0\)\
\-\ biopsy\\:\\ 0\\.04380582430035041\ \(0\)\
\-\ labs\\:\\ 0\\.04329617836764577\ \(0\)\
\-\ elevated\\:\\ 0\\.04260275721089959\ \(0\)\
\-\ followed\\:\\ 0\\.042201205018697806\ \(0\)\
\-\ back\\:\\ 0\\.04167876518999712\ \(0\)\
\-\ positive\\:\\ 0\\.04118010947245561\ \(0\)\
\-\ past\\:\\ 0\\.0406786300790008\ \(0\)\
\-\ examination\\:\\ 0\\.03998998099838799\ \(0\)\
\-\ proximal\\:\\ 0\\.03904249092813172\ \(0\)\
\-\ decreased\\:\\ 0\\.038709853249615706\ \(0\)\
\-\ year\\:\\ 0\\.0385186285311621\ \(0\)\
\-\ demonstrated\\:\\ 0\\.03840691933432529\ \(0\)\
\-\ when\\:\\ 0\\.037749784098756796\ \(0\)\
\-\ on\\:\\ 0\\.03774831336426387\ \(0\)\
\-\ focal\\:\\ 0\\.03738088015738992\ \(0\)\
\-\ secondary\\:\\ 0\\.03704156562506353\ \(0\)\
\-\ shows\\:\\ 0\\.036678369538633876\ \(0\)\
\-\ over\\:\\ 0\\.03474922002523223\ \(0\)\
\-\ chest\\:\\ 0\\.03298731824143711\ \(0\)\
\-\ were\\:\\ 0\\.032213673705490456\ \(0\)\
\-\ mri\\:\\ 0\\.03207869772425699\ \(0\)\
\-\ lower\\:\\ 0\\.03193432629421994\ \(0\)\
\-\ exam\\:\\ 0\\.031459337494278275\ \(0\)\
\-\ case\\:\\ 0\\.03139613301956763\ \(0\)\
\-\ large\\:\\ 0\\.031312423638878775\ \(0\)\
\-\ to\\:\\ 0\\.031246582294819157\ \(0\)\
\-\ female\\:\\ 0\\.030156071230932755\ \(0\)\
\-\ has\\:\\ 0\\.028545280972516334\ \(0\)\
\-\ by\\:\\ 0\\.02653843064338922\ \(0\)\
\-\ normal\\:\\ 0\\.025515740550465158\ \(0\)\
\-\ the\\:\\ 0\\.024939497464253706\ \(0\)\
\-\ from\\:\\ 0\\.024819830554460937\ \(0\)\
\-\ an\\:\\ 0\\.02389736413266146\ \(0\)\
\-\ old\\:\\ 0\\.018495608472037413\ \(0\)\
\-\ is\\:\\ 0\\.017114312172492124\ \(0\)\
